A new study details how a nasal spray formulated by investigators from Brigham and Women's Hospital may work to protect ...

Study explores the potential to repurpose neuroactive drugs, originally approved for neurological disorders, for the ...

A new study found a new drug-free nasal spray may protect against respiratory infections like COVID and the flu, Brigham and ...

Study found OV329 cleared and remained undetectable in the retina, eye, and brain tissues of mice, unlike vigabatrin which has repeatedly shown ...

HOOKIPA is very pleased to present a comprehensive preclinical proof-of-concept dataset related to HB-700, for the potential treatment of KRAS mutated cancers. KRAS mutations are most frequently found ...

In preclinical studies, a team of researchers from Mount Sinai Health System in New York City and City of Hope in Los Angeles have made significant strides in diabetes treatment. They discovered a ...

The growth of the global Preclinical CRO market is driven by several key factors. Increasing complexity and costs associated ...

PharmaLegacy Laboratories, a provider of in vitro and in vivo preclinical drug development services, has acquired BTS ...

Researchers from the Brigham detail how the spray they created may offer broad-spectrum protection from respiratory infections by COVID-19, influenza, everyday cold viruses, and pneumonia-causing bact ...

The Orphan Drug designation is supported by positive preclinical data from bleomycin-induced mouse models and patient-derived skin fibroblasts.

Mission Bio explains how single-cell multiomics can help researchers overcome the challenges of heterogeneous editing ...

Huadong Medicine Co. Ltd. recently revealed data from in vitro and preclinical studies performed to evaluate the efficacy and pharmacokinetic, safety and tolerability profiles of a dual glucagon-like ...